MOGS Sequence Analysis (Familial Mutation/Variant Analysis)
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000575595.1
INHERITED DISEASEMETABOLIC DISEASE
Last updated in GTR: 2020-03-09
Last annual review date for the lab: 2023-07-21 LinkOut
At a Glance
Diagnosis
MOGS-congenital disorder of glycosylation
Genes (1): Help
MOGS (2p13.1)
Molecular Genetics - Targeted variant analysis: Bi-directional Sanger Sequence Analysis
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
Test Order Code: Help
29186
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
Bi-directional Sanger Sequence Analysis
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
This test has more than 99% analytical sensitivity for detecting substitution variants and small indels in the target region.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.